The global fibromyalgia treatment market is projected to expand from USD 2.77 billion in 2023 to approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5139
Fibromyalgia affects around 4 million adults in the United States, roughly 2% of the adult population. While the exact cause remains unknown, effective treatment options are available. As the need for these treatments grows, researchers are exploring new approaches beyond traditional medications.
Fibromyalgia is characterized by widespread muscle pain, fatigue, difficulty concentrating, and other emotional and physical symptoms. Although people with fibromyalgia experience pain in muscles and soft tissues, there is no visible inflammation in these areas.
Research suggests that fibromyalgia may be linked to how the body processes pain, a condition known as central sensitization syndrome. It is more common in women, with approximately 6.4% of the U.S. population affected (7.7% in women and 4.9% in men). Studies in Europe and South America show similar rates, ranging from 3.3% to 8.3%. Fibromyalgia is more prevalent as people age, often affecting women between the ages of 20 and 55. Teenagers can also experience fibromyalgia at similar rates as adults, and in specialized pain clinics, over 40% of patients meet the criteria for the condition.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/fibromyalgia-treatment-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5139
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The Molecular Cloning Market is expected to continue its growth trajectory with a projected increase from $5.53 billion in 2025… Read More
The global pharma CRO services market is on a solid growth path. It’s expected to jump from USD 36.66 billion… Read More
The use of Artificial Intelligence (AI) in mental health care is growing fast. In 2024, this market was worth about… Read More
The global cancer vaccines market is on a strong growth path. It's expected to expand from $11.38 billion in 2025… Read More
The global bioprocess containers market is on a major growth path. Valued at around $3.12 billion in 2024, it’s expected… Read More
The world is moving towards personalized healthcare, and patient-centric apps are at the forefront of this shift. In 2024, the… Read More